The triggering receptor expressed on myeloid cells 2 (TREM2)/apolipoprotein E (APOE) pathway has been in the focus of microglia analysis since it was shown that this pathway is important during Alzheimer’s disease progression as well as during EAE/MS (82, 94). This evidence concerns the gene APOE and myeloid sarcoma.